MacroGenics | MGNX - Işletim Giderleri





Işletim Giderleri Değişiklik Tarih
AbbVie USD 10.27B 1000K 2026-06
Amgen USD 11.69B 6.9B 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Biogen USD 2.32B 663.6M 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Daiichi Sankyo JPY 489.64B 21.08B 2026-06
Eli Lilly USD 10.52B 496M 2026-06
Genmab DKK 748M 77M 2026-06
Geron USD 52.07M 6.73M 2026-03
Gilead Sciences USD 13.04B 9.09B 2026-09
J&J USD 18.93B 1.09B 2026-09
Karyopharm Therapeutics USD 61.83M 9.9M 2026-03
MacroGenics USD 42.87M 21.68M 2026-06
Merck USD 10.75B 5.02B 2026-09
Pfizer USD 85.19B 4.91B 2026-06
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Xencor USD 87.82M 5.44M 2026-06